Artwork for podcast Connections: Investment Matters
Research in Action: Investing through the Ups and Downs of Biopharma Research
25th July 2022 • Connections: Investment Matters • Janus Henderson Investors
00:00:00 00:40:18

Share Episode


Even as biopharmaceutical firms continue to deliver exciting medical advances, the sector’s performance has been mixed this year, with some firms negatively impacted by rising rates, clinical trial setbacks and regulatory uncertainty and others benefiting from strong free cash flows. Portfolio Manager Dan Lyons and Research Analyst Luyi Guo explain how investors might gain exposure to the sector’s secular growth opportunities, while minimizing downside risks.